Investigation on the current status of pharmaceutical care in medical institutions in China
- VernacularTitle:我国医疗机构药学监护开展现状调查
- Author:
Tingting ZHENG
1
;
Yuqing ZHANG
2
,
3
;
Sitong LIU
1
;
Wei ZHANG
1
;
Jin LU
3
;
Qunhong SHEN
3
,
4
;
Jiancun ZHEN
1
Author Information
1. Dept. of Pharmacy，Beijing Jishuitan Hospital，Capital Medical University，Beijing 100035，China
2. School of Pharmaceutical Sciences，Peking University，Beijing 100191，China
3. Pharmaceutical Specialized Committee，Chinese Hospital Association，Beijing 100035，China
4. Health and Development Institute，School of Public Policy & Management，Tsinghua University，Beijing 100084，China
- Publication Type:Journal Article
- Keywords:
pharmaceutical care;
current status;
questionnaire survey;
influencing factors
- From:
China Pharmacy
2025;36(9):1117-1122
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To investigate the current status of pharmaceutical care in medical institutions in China， and provide experience and suggestions for better development of pharmaceutical care. METHODS Questionnaire survey was used to investigate the development of pharmaceutical care in medical institutions in 31 provinces （autonomous regions and municipalities directly） in March 2023， and descriptive analysis and binary logistic regression analysis on the influencing factors of pharmaceutical care were conducted. RESULTS A total of 1 368 questionnaires were sent out， and 1 304 valid questionnaires were collected with the effective recovery rate of 95.32%. Pharmaceutical care was carried out in 671 medical institutions （51.46%）， and the rates of pharmaceutical care in tertiary， secondary， primary and other medical institutions were 74.79%， 27.97% and 7.35%， respectively. The average number of patients receiving pharmaceutical care was 2 638.96 per year， and there were 8.33 pharmacists in each medical institution to carry out pharmaceutical care， among which 93.68% were clinical pharmacists. The main departments covered by pharmaceutical care services included respiratory and critical care medicine， cardiology， intensive care unit， endocrinology， oncology， gastroenterology， obstetrics and gynecology and other departments. There were only 48 medical institutions （7.15%） with additional compensation for pharmaceutical care services. The main experiences of developing pharmaceutical care were to pay attention to talent cultivation and discipline construction， but the main difficulties were serious shortage of staff and qualified talents， low compensation level and low enthusiasm. Grade of medical institutions， the number of pharmacists engaged in clinical pharmacy， the number of qualified clinical pharmacists and the degree of information in the pharmacy department were the main influencing factors for carrying out pharmaceutical care （P＜0.05）. CONCLUSIONS In recent years， pharmaceutical care in Chinese medical institutions has made certain progress， while that of primary medical institutions， secondary medical institutions and other medical institutions should be improved. In the future， it is still necessary to further enhance the implementation of pharmaceutical care， promote personnel training， and attach importance to demonstrating the value of pharmaceutical care， thereby promoting the sustainable and high- quality development of pharmaceutical care.
